Discover
ACTU
Actuate Therapeutics, Inc. Common stock
1.44
2 x 1.50
1 x 1.53
bid
ask
-
0.09
5.88%
2 @ 04:00 AM
1.45 +0.01 (0.69%)
| Ytd | -76.47% | |
| 1y | -76.51% |
1.40
day range
1.55
1.40
52 week range
9.22
| Open | 1.54 | Prev Close | 1.53 | Low | 1.40 | High | 1.55 | Mkt Cap | 34.45M |
| Vol | 134.73K | Avg Vol | 181.05K | EPS | -0.98 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.49 | Inst. Own | 53.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.35 | 200-d Avg | 4.60 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 5.71M | ||
| Research and Development Expense | 2.57M | ||
| Selling, General and Administrative Expense | 3.14M | ||
| Operating Income | -5.71M | ||
| Interest Expense | 5.06K | ||
| Net Income | -5.63M | ||
| Net Income Common Stock | -5.63M | ||
| Net Income Common Stock (USD) | -5.63M | ||
| Consolidated Income | -5.63M | ||
| Earnings per Basic Share | -0.24 | ||
| Earnings per Basic Share (USD) | -0.24 | ||
| Earnings per Diluted Share | -0.24 | ||
| Earning Before Interest & Taxes (EBIT) | -5.62M | ||
| Earning Before Interest & Taxes (USD) | -5.62M | ||
| Weighted Average Shares | 23.54M | ||
| Weighted Average Shares Diluted | 23.54M | ||
| Balance Sheet | |||
| Cash and Equivalents | 8.13M | ||
| Cash and Equivalents (USD) | 8.13M | ||
| Current Assets | 8.52M | ||
| Total Assets | 8.91M | ||
| Current Liabilities | 4.72M | ||
| Total Liabilities | 5.13M | ||
| Accumulated Retained Earnings (Deficit) | -160.23M | ||
| Shareholders Equity | 3.78M | ||
| Shareholders Equity (USD) | 3.78M | ||
| Assets Non-Current | 391.84K | ||
| Liabilities Non-Current | 404.99K | ||
| Trade and Non-Trade Payables | 1.61M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -8.09K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.03M | ||
| Issuance (Purchase) of Equity Shares | 519.62K | ||
| Net Cash Flow from Operations | -5.02M | ||
| Share Based Compensation | 1.36M | ||